Aker BioMarine AS reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was USD 82.9 million compared to USD 79 million a year ago. Net income was USD 9.9 million compared to USD 0.2 million a year ago.

Basic earnings per share from continuing operations was USD 0.11. Diluted earnings per share from continuing operations was USD 0.11.